Related references
Note: Only part of the references are listed.To measure or not to measure direct oral anticoagulants before surgery or invasive procedures
A. Tripodi
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery
A. C. Spyropoulos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
James D. Douketis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations
Anne Godier et al.
THROMBOSIS RESEARCH (2015)
Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures
David Garcia et al.
BLOOD (2014)
Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
Matthew W. Sherwood et al.
CIRCULATION (2014)
Perioperative Management of Antithrombotic Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines
James D. Douketis et al.
CHEST (2012)
Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists Systematic Review and Meta-Analysis of Bleeding and Thromboembolic Rates
Deborah Siegal et al.
CIRCULATION (2012)
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial
Jeff S. Healey et al.
CIRCULATION (2012)
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy
A. C. SPYROPOULOS et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Share Paper
